Polypill therapy and frailty in elderly: Time to stop treating everything

Authors

  • Sunil Kumar Professor, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India https://orcid.org/0000-0001-9905-4831
  • Parth Godhiwala Post Graduate Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India https://orcid.org/0000-0003-0869-9816
  • Amrutha Garikapati Post Graduate Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India https://orcid.org/0000-0003-0998-9874
  • Shraddha Jain Professor, Department of ENT, Jawahar Lal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Wardha, Maharashtra, India https://orcid.org/0000-0003-1455-1850

DOI:

https://doi.org/10.3126/ajms.v12i4.33182

Keywords:

Elderly, Frail, Hospitalization, Mortality, Polypill

Abstract

Background: Frailty is a reversible age-related condition of increased vulnerability and risk of death or unplanned hospitalization. Frailty and polypill therapy are common in elderly, although little is known about the impact, they may have on each other.

Aims and Objective: The study was a prospective observational study, designed with an aim to observe the six-month and one-year outcomes of elderly patients on polypill therapy.

Material and Methods: Three hundred forty-two patients aged more than 60 years on polypill treatment were enrolled in this study, which were on regular follow up in our rural hospital at geriatric units of medicine department.

Results: At the end of one year, 38.1% were in severe frailty (FIRE >0.7) category, out of which death happened at the end of one year were 41.6%. 47.6% required repeated hospitalisations that were on polypill therapy.

Conclusions: A reduction of polypill therapy could be a cautious strategy to prevent and manage frailty. Further research is needed to confirm the possible benefits of reducing polypill in the development, reversion or delay of frailty.

Downloads

Download data is not yet available.
Abstract
266
PDF
349
Cover AJMS

Downloads

Published

2021-04-01

How to Cite

Kumar, S., Godhiwala, P., Garikapati, A., & Jain, S. (2021). Polypill therapy and frailty in elderly: Time to stop treating everything. Asian Journal of Medical Sciences, 12(4), 39–42. https://doi.org/10.3126/ajms.v12i4.33182

Issue

Vol. 12 No. 4 (2021)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).